21 C.F.R. §1301.74 - Other security controls for non-practitioners; narcotic treatment programs and compounders for narcotic treatment programs; mobile narcotic treatment programs

Cite as21 C.F.R. §1301.74
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
50 cases
  • City of S.F. v. Purdue Pharma L.P., Case No. 3:18-cv-07591-CRB
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Northern District of California
    • September 30, 2020
    ...and distributors—to "design and operate a system to disclose to the registrant suspicious orders of controlled substances." 21 C.F.R. 1301.74(b). The MDL court concluded that these regulations impose duties on manufacturers and distributors to identify, report, and refrain from shipping sus......
  • Walmart Inc. v. U.S. Dep't of Justice, CIVIL NO. 4:20-CV-817-SDJ
    • United States
    • United States District Courts. 5th Circuit. United States District Court of Eastern District Texas
    • February 4, 2021
    ...suspicious orders of controlled substances" and to notify DEA of such "suspicious orders" when discovered by the registrant. 21 C.F.R. § 1301.74(b). The regulation defines "suspicious orders" to include "orders of unusual size, orders deviating substantially from a normal pattern, and order......
  • Rochester Drug Co-Operative, Inc. v. Hiscox Ins. Co., 6:20-CV-06025 EAW
    • United States
    • United States District Courts. 2nd Circuit. United States District Court of Western District of New York
    • June 11, 2020
    ...substances made by its pharmacy customers that should have been reported as suspicious pursuant to the criteria set forth in 21 C.F.R. § 1301.74(b) and the guidance contained in the DEA Letters.(Dkt. 15 at 309).Plaintiff does not conclusively admit to deliberately committing a crime or deli......
  • Walmart Inc. v. U.S. Dep't of Justice, Civil No. 4:20-CV-817-SDJ
    • United States
    • United States District Courts. 5th Circuit. United States District Court of Eastern District Texas
    • February 4, 2021
    ...suspicious orders of controlled substances" and to notify DEA of such "suspicious orders" when discovered by the registrant. 21 C.F.R. § 1301.74(b). The regulation defines "suspicious orders" to include "orders of unusual size, orders deviating substantially from a normal pattern, and order......
  • Request a trial to view additional results
9 firm's commentaries
2 provisions
  • Act 443, SB 39 – HEALTH CARE: Provides for the Louisiana Board of Drug and Device Distributors
    • United States
    • Louisiana Session Laws
    • January 1, 2015
    ...in Louisiana and excessive controlled substance purchase reports for all controlled substance registrants in Louisiana required by 21 CFR 1301.74(b) as requested by the Louisiana Board of Pharmacy. Notwithstanding any other law to the contrary, these reports shall be confidential and shall ......
  • P.A. 19-0191, HB 7159 – AN ACT ADDRESSING OPIOID USE
    • United States
    • Connecticut Session Laws
    • January 1, 2019
    ...Division a copy of any suspicious [activity reporting] orders submitted to the federal Drug Enforcement Administration pursuant to 21 CFR 1301.74.(2) Each registered manufacturer or wholesaler of drugs that, based on concerns of potential diversion, ceases or declines distribution of any sc......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT